---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003887"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T16:00:13.152635+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nasdaq grants Daré extension until Aug 12, 2025 to regain listing compliance

## Summary
- Extension conditional on meeting stockholders' equity >$2.5M by April 30, 2025 and further increase by July 15, 2025.
- Company must publicly disclose equity-raising transactions and provide 12-month projections by August 12, 2025.
- Non-compliance with Nasdaq Rule 5550(b) since August 2024; risk of delisting if conditions not met.
- Panel may reconsider extension or delist after April 30 if plan execution falters.

## SEC filing metadata
- accession: 0001641172-25-003887
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000164117225003887/0001641172-25-003887-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000164117225003887/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003887
- JSON: https://secwatch.observer/filing/0001641172-25-003887.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003887.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.